相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans
Jesse C. Nussbaum et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
Lorcan P McGarvey et al.
LANCET (2022)
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
Alyn H. Morice et al.
LUNG (2021)
Patient-Reported Burden of Chronic Cough in a Managed Care Organization
Robert S. Zeiger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Prevalence and Burden of Chronic Cough in the United States
Eli O. Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
Alyn H. Morice et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
Jaclyn A Smith et al.
Lancet Respiratory Medicine (2020)
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough
Peter V. Dicpinigaitis et al.
LUNG (2020)
The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough
Giacomo Campi et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
David R. Muccino et al.
ERJ OPEN RESEARCH (2020)
Gefapixant in two randomised dose-escalation studies in chronic cough
Jaclyn A. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
What Is Chronic Cough? Terminology
Lorcan McGarvey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Classification of Cough as a Symptom in Adults and Management Algorithms CHEST Guideline and Expert Panel Report
Richard S. Irwin et al.
CHEST (2018)
Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation
Anthony Fenton et al.
BMC NEPHROLOGY (2018)
Risk Factors for Chronic Cough Among 14,669 Individuals From the General Population
Yunus Colak et al.
CHEST (2017)
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
Rayid Abdulqawi et al.
LANCET (2015)
The Impact of Chronic Cough: A Cross-Sectional European Survey
Sarah A. F. Chamberlain et al.
LUNG (2015)
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
Hideaki Kouzaki et al.
JOURNAL OF IMMUNOLOGY (2011)
P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus
Kevin Kwong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells
Marco Idzko et al.
NATURE MEDICINE (2007)
分享论文
